Neural and hormonal regulation of pancreatic secretion

Current Opinion in Gastroenterology

Volumn 25, Issue 5, 2009, Pages 441-446

  Chandra, Rashmi ^a   Liddle, Rodger A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Endocrine; Exocrine; Pancreas; Regulation; Secretion

Indexed keywords

AMYLASE; CALCIUM; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ OCTAPEPTIDE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; LEPTIN; MELATONIN; NATRIURETIC PEPTIDE TYPE C; NEUROPEPTIDE Y; OBESTATIN; OREXIN A; OREXIN B;

ACINAR CELL; AMYLASE RELEASE; CIRCADIAN RHYTHM; DIABETES MELLITUS; ENDOCRINE FUNCTION; ENERGY BALANCE; EXOCRINE SECRETION; FOOD INTAKE; HOMEOSTASIS; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HYPOTHALAMUS; INSULIN RELEASE; MOTONEURON NUCLEUS; NERVE CELL; NERVE TRACT; NEUROENDOCRINE SYSTEM; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET; PANCREAS SECRETION; PANCREATITIS; REVIEW; SIGNAL TRANSDUCTION; VAGUS NERVE;

CHOLECYSTOKININ; GHRELIN; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; MELATONIN; NEUROPEPTIDES; PANCREAS; PANCREAS, EXOCRINE; VAGUS NERVE;

EID: 69749088076     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32832e9c41     Document Type: Review

References (38)

1. Liddle RA. Cholecystokinin. In: Walsh JH, Dockray GJ, editors. Gut peptides: biochemistry and physiology. New York: Raven Press; 1994. pp. 175-216.
2. Liddle RA. Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay. Gastroenterol Clin North Am 1989;18:735-756.
3. Singer MV, Niebergall-Roth E. Secretion from acinar cells of the exocrine pancreas: role of enteropancreatic reflexes and cholecystokinin. Cell Biol Int 2009; 33:1-9.
4. Viard E, Zheng Z, Wan S, et al. Vagally mediated, nonparacrine effects of cholecystokinin-8s on rat pancreatic exocrine secretion. Am J Physiol Gastrointest Liver Physiol 2007; 293:G493-G500. (Pubitemid 47263196)
5. Wan S, Coleman FH, Travagli RA. Cholecystokinin-8s excites identified rat pancreatic-projecting vagal motoneurons. Am J Physiol Gastrointest Liver Physiol 2007; 293:G484-G492. (Pubitemid 47263195)
6. 2+ signaling and enzyme secretion by cholecystokinin in human pancreatic acinar cells. Gastroenterology 2008; 135:632-641. This was the first study to show that CCK-8 and CCK-58 can act directly on human pancreatic acinar cells to elicit exocrine secretion.
7. Kirchgessner AL, Gershon MD. Presynaptic inhibition by serotonin of nerve-mediated secretion of pancreatic amylase. Am J Physiol Gastrointest Liver Physiol 1995; 268:G339-G345.
8. Li Y, Wu XY, Zhu JX, et al. Intestinal serotonin acts as paracrine substance to mediate pancreatic secretion stimulated by luminal factors. Am J Physiol Gastrointest Liver Physiol 2001; 281:G916-G923. (Pubitemid 32953149)
9. Mussa BM, Sartor DM, Verberne AJM. Activation of cholecystokinin (CCK1) and serotonin (5-HT3) receptors increases the discharge of pancreatic vagal afferents. Eur J Pharmacol 2008; 601:198-206. This article showed that cholecystokinin and serotonin mediate pancreatic secretion by activating CCK1 and 5-HT3 receptors located on dorsal vagal afferents. Whereas CCK did not activate serotonin receptors, phenylbiguanide, a serotonin receptor agonist, increased pancreatic secretion by stimulating CCK1 receptors.
10. Nawrot-Pora̧bka K, Jaworek J, Leja-Szpak A, et al. Involvement of vagal nerves in the pancreatostimulatory effects of luminal melatonin, or its precursor L-tryptophan. Study in the rats. J Physiol Pharmacol 2007; 58 (Suppl 6):81-95.
11. 2+ signals and mitochondrial membrane potential in exocrine cells are prevented by melatonin. J Pineal Res 2008; 45:191-198. Oral administration of melatonin restored calcium oscillations and exocrine secretion in aging acinar cells.
12. Jaworek J, Nawrot-Porabka K, Leja-Szpak A, et al. Melatonin as modulator of pancreatic enzyme secretion and pancreatoprotector. J Physiol Pharmacol 2007; 58 (Suppl 6):65-80. (Pubitemid 47212525)
13. Sabbatini ME. Natriuretic peptides as regulatory mediators of secretory activity in the digestive system. Regul Pept 2009; 154:5-15.
14. Sabbatini ME, Rodriguez MR, Dabas P, et al. C-type natriuretic peptide stimulates pancreatic exocrine secretion in the rat: role of vagal afferent and efferent pathways. Eur J Pharmacol 2007; 577:192-202. (Pubitemid 47632536)
15. Linari G, Agostini S, Amadoro G, et al. Involvement of cannabinoid CB1- and CB2-receptors in the modulation of exocrine pancreatic secretion. Pharmacol Res 2009; 59:207-214. This article showed that CB1 and CB2 were expressed in acinar cells of rat. Activation of the receptors decreased amylase release possibly by inhibiting release of acetylcholine from the presynaptic terminals.
16. 2+ oscillation in islet b-cells via CB1 receptors. Regulatory Peptides Satellite Symposium on G-Protein-Couples receptors (GPCRs) September 2, 2006 Hakone, Japan. 2008; 145:49-53. This article demonstrated endogenous endocannabinoid ligands inhibit the release of insulin from mouse beta cells.
17. Bermudez-Silva FJ, Suarez J, Baixeras E, et al. Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia 2008;51:476-487. This study showed that CB1 receptor was expressed in human glucagon and insulin-producing cells, but was absent in the acinar cells. Stimulation of CB1 caused the release of insulin from dissociated islet cells.
18. Izzo AA, Camilleri M. Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects. Gut 2008; 57:1140-1155.
19. Bermudez-Silva FJ, Suarez Perez J, Nadal A, et al. The role of the pancreatic endocannabinoid system in glucose metabolism. Best Pract Res Clin Endocrinol Metab 2009; 23:87-102.
20. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999; 402:656-660. (Pubitemid 129516334)
21. Lai KC, Cheng CH, Leung PS. The ghrelin system in acinar cells: localization, expression, and regulation in the exocrine pancreas. Pancreas 2007;35:e1-e8.
22. Nawrot-Porabka K, Jaworek J, Leja-Szpak A, et al. The effect of luminal ghrelin on pancreatic enzyme secretion in the rat. Regul Pept 2007; 143:56-63. (Pubitemid 47212525)
23. Qader SS, Hakanson R, Rehfeld JF, et al. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas. Regul Pept 2008; 146:230-237. This study demonstrated that the three pro-ghrelin-derived peptides (acyl ghrelin, desacyl ghrelin, and obestatin) had either similar or opposing roles in endocrine secretion.
24. Zhang JV, Ren P-G, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene opposes ghrelin's effects on food intake. Science 2005;310:996-999. (Pubitemid 41611907)
25. Granata R, Settanni F, Gallo D, et al. Obestatin promotes survival of pancreatic β-cells and human islets and induces expression of genes involved in the regulation of b-cell mass and function. Diabetes 2008; 57:967-979. In addition to stimulating insulin release, obestatin had a proliferative and antiapoptotic effect on beta cells. This finding has clinical implications in the treatment of diabetes.
26. Heinonen MV, Purhonen AK, Mäkelä KA, et al. Functions of orexins in peripheral tissues. Acta Physiol 2008; 192:471-485.
27. Göncz E, Strowski MZ, Grotzinger C, et al. Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathway. Endocrinology 2008; 149:1618-1626. This study showed that orexin A modulated proglucagon gene expression via a pathway mediated by intracellular calcium, CREB, and Foxo1 transcription factor.
28. O'Carroll AM, Howell GM, Roberts EM, et al. Vasopressin potentiates corticotropin-releasing hormone-induced insulin release from mouse pancreatic beta-cells. J Endocrinol 2008; 197:231-239. This was the first study to show that AVP potentiated CRH-mediated insulin release from islets by a mechanism dependent on AVPR1b, PKC, and intracellular calcium.
29. Grandt D, Siewert J, Sieburg B, et al. Peptide YY inhibits exocrine pancreatic secretion in isolated perfused rat pancreas by Y1 receptors. Pancreas 1995;10:180-186.
30. Kojima S, Ueno N, Asakawa A, et al. A role for pancreatic polypeptide in feeding and body weight regulation. Peptides 2007; 28:459-463. (Pubitemid 46176251)
31. Imai Y, Patel HR, Hawkins EJ, et al. Insulin secretion is increased in pancreatic islets of neuropeptide Y-deficient mice. Endocrinology 2007; 148:5716-5723. (Pubitemid 350146158)
32. Holst JJ, Deacon CF, Vilsbøll T, et al. Glucagon-like peptide-1, glucose homeostasis and diabetes. Trends Molec Med 2008; 14:161-168.
33. Wan S, Coleman FH, Travagli RA. Glucagon-like peptide-1 excites pancreas-projecting preganglionic vagal motoneurons. Am J Physiol Gastrointest Liver Physiol 2007; 292:G1474-G1482. (Pubitemid 47080600)
34. de Heer J, Rasmussen C, Coy DH, et al. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas. Diabetologia 2008; 51:2263-2270. This study suggested that GLP-1 inhibited glucagon release via a pathway mediated by somatostatin.
35. Sonoda N, Imamura T, Yoshizaki T, et al. β-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells. Proc Natl Acad Sci U S A 2008; 105:6614-6619. (Pubitemid 351754555)
36. Salehi A, Meidute Abaraviciene S, Jimenez-Feltstrom J, et al. Excessive islet NO generation in type 2 diabetic GK rats coincides with abnormal hormone secretion and is counteracted by GLP-1. PLoS ONE 2008;3:e2165. This study showed that GLP-1 restored insulin secretion from islets of type 2 diabetic rats by inhibiting nitric oxide signaling. (Pubitemid 352025143)
37. Halaas JL,Gajiwala KS, Maffei M, et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269:543-546.
38. Morioka T, Asilmaz E, Hu J, et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest 2007; 117:2860-2868. (Pubitemid 47529616)